Ashleigh Golden
Adjunct Clinical Assistant Professor of Psychiatry and Behavioral Sciences @ Stanford University School of Medicine
Ashleigh Golden is a clinical psychologist licensed in California and Missouri and registered in British Columbia, Canada. She is a Diplomate of the Academy of Cognitive Therapy and is registered as a Health Service Provider in both the U.S. and Canada.
She serves as an adjunct clinical assistant professor of psychiatry and behavioral sciences at Stanford University School of Medicine and consults clinicians across North America on complex OCD and anxiety-related cases. Ashleigh is recognized as a Forbes Healthcare Innovator and a Top Product Development Voice on LinkedIn. She held senior roles at Woebot Health, Lark Health, Brightside Health, YouTube, Google’s national EAP, and Meta, and consulted extensively with health tech companies, including Grow Therapy, Meru Health, BeMe, OxfordVR, Healthline Media, MDisrupt, and Redesign Health. She was also a founding member of Therapists in Tech, and serves on the Society of Digital Mental Health’s industry special interest group and the Digital Therapeutics Alliance’s Clinician Education Task Group.
Ashleigh specializes in translational science, equipping nonclinical, cross-functional teammates with actionable insights based on key ‘active ingredients’ (mechanisms) from cutting-edge clinical and applied behavioral science in digital contexts, as well as continuously optimizing products and programs for uptake, engagement, adherence, retention, effectiveness, safety, treatment fidelity, and cultural responsiveness. She completed her doctorate at the PGSP-Stanford PsyD Consortium and a 2-year subspecialized postdoctoral fellowship in CBT and ERP at the Center for OCD and Anxiety-Related Disorders at the Saint Louis Behavioral Medicine Institute, and is currently pursuing a part-time postdoctoral master’s in clinical psychopharmacology through Fairleigh Dickinson University.
